Evolent Health (EVH)
(Delayed Data from NYSE)
$31.98 USD
+0.12 (0.38%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $31.99 +0.01 (0.03%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth D Momentum B VGM
Price, Consensus and EPS Surprise
EVH 31.98 +0.12(0.38%)
Will EVH be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for EVH based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for EVH
Evolent Health (EVH) Reports Q2 Earnings: What Key Metrics Have to Say
Evolent Health (EVH) Surpasses Q2 Earnings and Revenue Estimates
EVH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Evolent Health (EVH) Moves 12.8% Higher: Will This Strength Last?
Evolent Health (EVH) Reports Q1 Earnings: What Key Metrics Have to Say
Evolent Health (EVH) Q1 Earnings and Revenues Top Estimates
Other News for EVH
Campbell: Fiscal Q4 Earnings Snapshot
Evolent Health dips on report Elevance dropped out of bidding
Truist Financial Sticks to Its Buy Rating for Evolent Health (EVH)
Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY) and Evolent Health (EVH)
Evolent Health (EVH) Gets a Buy from RBC Capital